Beam is looking for a highly motivated, passionate, and collaborative marketer to join our growing Product & Portfolio Strategy team. The Product Director, BEAM-101 will shape the development and execution of the U.S. launch plan for Beam’s lead asset, BEAM-101, an ex vivo autologous hematopoietic stem cell-based gene therapy for the treatment of severe sickle cell disease (SCD).
Beam is looking for a highly motivated, passionate, and collaborative marketer to join our growing Product & Portfolio Strategy team. The Product Director, BEAM-101 will shape the development and execution of the U.S. launch plan for Beam’s lead asset, BEAM-101, an ex vivo autologous hematopoietic stem cell-based gene therapy for the treatment of severe sickle cell disease (SCD). In this role, you will be a critical member of a highly cross-functional team preparing for Beam’s potential first product commercialization.
Responsibilities:
Responsible for generating insights into the sickle cell and genetic medicines treatment landscape, stakeholder needs and treatment decision making
Leads development of the BEAM-101 brand plan, including competitive differentiation, customer segmentation and targeting, positioning, and messaging
Contributes to the development and execution of the integrated launch plan for BEAM-101
Collaborates with other functions (e.g. medical affairs, market access, patient supply, patient advocacy) in shaping HCP engagement strategy, customer experience, disease state education etc.
Leads development of short- and long-term professional marketing strategies and tactics
Budget management
Forecast and long-range financial planning
Competitive monitoring
Qualifications:
BS/BA in a relevant academic field; MBA, MD, PhD, or other graduate degree strongly preferred
Minimum 10 years business experience within the pharma/biotech/biopharma space